Launch of New Therapies Amplifies Competition in the Dry Eye Disease Pipeline Landscape, Pronounces DelveInsight

2021-07-08

Los Angeles, USA, July 07, 2021 (GLOBE NEWSWIRE) -- Launch of New Therapies Amplifies Competition in the Dry Eye Disease Pipeline Landscape, Pronounces DelveInsight The Dry Eye disease pipeline represents a number of promising therapies in clinical development with novel mechanisms of action (MOAs) ranging from Chemokine receptor antagonists, Syk kinase inhibitors Syk kinase inhibitors, Lipid modulators, Protein tyrosine kinase inhibitors, Dihydroorotate dehydrogenase inhibitors, Melanocortin type 1 receptor agonists, Melanocortin type 5 receptor agonists, and so many others. DelveInsight’s ‘Dry Eye Disease (DED) Pipeline Insights’ report presents an exhaustive coverage of the available therapies, Dry Eye Disease emerging therapies in different phases of clinical development, key companies working in the Dry Eye Disease pipeline domain, and future potential of the space. Some of the focal points picked from the Dry Eye Disease Pipeline report: Request for Sample to know more about the therapies expected to make grab the maximum patient pool @ Dry Eye Disease Emerging Therapies and Forecast The Dry Eye Disease Pipeline reports offer a holistic scenario of the ongoing clinical trials, partnerships taking place in the domain, recent happenings in space, and growth prospects across the Dry Eye Disease domain. Dry Eye Disease: Overview Dry Eye Disease (DED) is a complex, multifactorial condition that causes inflammation of the ocular surface and lacrimal glands and reductions in the quality and/or quantity of tears. It results in visual disturbance, and tear film instability with potential damage to the ocular surface. Discover more about the disease, treatments, and pipeline therapies @ DED Pipeline Assessment Dry Eye Disease Pipeline Drugs Request for Sample to know more @ Dry Eye Disease Pipeline Analysis, Key Companies, and Futuristic Trends Dry Eye Disease Therapeutics Assessment The Dry Eye Disease Pipeline report presents a kaleidoscopic view of the DED emerging novel therapies segmented by Stage, Product Type, Route of Administration, Molecule Type, Target, and Mechanism of Action. By Product Type By Stage By Molecule Type By Route of Administration By Mechanism of Action By Targets For rich insights into merging therapies and assessment, visit Dry Eye Disease Pipeline: Emerging Novel Therapies Scope of the Dry Eye Disease Pipeline Report Coverage: GlobalKey Players: Cellix Bio, AbbVie, IACTA Pharmaceuticals, Novaliq, Ocumension Therapeutics, Panoptes Pharma, Palatin Technologies, Aldeyra Therapeutics, among others.Key Dry Eye Disease Pipeline Therapies: CLX-OPH-621, AGN-231868, IC-265, NOV03, OT-202, PP 001, PL 9643, Reproxalap, and others. Discover more about the scope of the report @ DED Emerging Therapies, Treatments, and Ongoing Clinical Trials Table of Contents Learn more about the report offerings @ Dry Eye Disease Pipeline Therapies and Emerging Trends Audit the market before venturing with DelveInsight’s Due Diligence Services Related Reports Dry Eye Disease MarketDelveInsight's "Dry Eye Disease (DED) Market Insights, Epidemiology and Market Forecast-2028" report. Vernal Keratoconjunctivitis MarketDelveInsight's "Vernal keratoconjunctivitis Market Insights, Epidemiology, and Market Forecast-2030" report. Adult Myopia MarketDelveInsight’s ‘Adult Myopia Market Insights, Epidemiology, and Market Forecast—2030’ report. Blepharitis MarketDelveInsight's "Blepharitis Market Insights, Epidemiology, and Market Forecast-2030" report. Central Retinal Vein Occlusion MarketDelveInsight's "Central Retinal Vein Occlusion Market Insights, Epidemiology, and Market Forecast-2030" report. Central Serous Chorioretinopathy MarketDelveInsight's "Central Serous Chorioretinopathy Market Insights, Epidemiology, and Market Forecast-2030" report. Centronuclear Myopathy MarketDelveInsight’s ‘Centronuclear Myopathy Market Insights, Epidemiology, and Market Forecast-2030’ report. Browse through our related posts Uveitis Pipeline TherapiesEye Disorders Treatment MarketKeratoconus Therapy Market Allergic Conjunctivitis Therapy Market and Pipeline AnalysisDiabetic Macular Edema Market and dominance of off-label Avastin (Roche/Genentech) About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve. For more insights, visit Pharma, Healthcare, and Biotech News

机构